Greetings, My name is 최승훈 the developer of the PIPE-11
My vision is contribution to the improvement of human health by pursuing integrated medicine centered on oriental medicine. In order to do that, first of all, Oriental medicine must be standardized, and based on it, patient-centered medical care must be pursued as universal medicine.
From 1995 to 1998, I have been leading the project called “Standardization and unification of the terms and conditions used for diagnosis in oriental medicine”. That was an important task at the KIOM (Korea Institute of Oriental Medicine). Based on the research results, the concept and contents of dialectic were introduced to Korea, and the fields of oriental medicine pathology and diagnostics began to gain full-fledged competencies.
After the KIOM project, I developed KHU-PIPE, the first clinical decision support system in the oriental medicine field in 2000, and launched the Web-based OMS-Prime in 2002. And these have been used clinically by about 3,000 oriental medical doctors, and have been used as educational materials in 3 oriental medicine universities. However, I worked as the head of traditional medicine field at the World Health Organization (WHO) for 5 years from 2003, then returned to Kyunghee University and worked as the dean of Oriental Medicine University. I came back to the KIOM as a president at 2011 however, I didn't get a chance to making improvement of OMS-Prime system.
In 2019, WHO announced ICD-11, which includes the oriental medicine part. Now, as oriental medicine appears in the global medical field in earnest, we have an opportunity to receive verification. For that, a clinical decision support system that can accurately contain vast and effective knowledge and technology of oriental medicine is essential.
In response to the demands of this era, we have developed PIPE-11 that can accommodate the contents of traditional medicine included in ICD-11 and can be used in various fields in actual clinical education and research.
The financial and technical support of OKCHUNDANG Co., Ltd., a leader of oriental herbal pharmaceutical industry, has been a great help. This is the result of full-scale industry-university-joint research. I hope that PIPE-11 using artificial intelligence will become a driving force for clinical education research in the field of oriental medicine in the future while accepting ICD-11.